Sort   by:  
 Page size 
ProteomicsProteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion
In blood banks, platelets are stored until 7 days after a pathogen reduction technology (PRT) treatment, Mirasol® (vitamin B2 plus UVB light) in the present case. The storage time under these conditions may have an impact on platelets and their releasate leading to potential adverse reactions follow...
ORGANISM(S): Homo sapiens (Human) 
2022-09-30 | PXD014694 | Pride
Extracellular vesicles  platelet concentrates  transfusion medicine  swath 
ProteomicsPlatelet proteomics profiling in transfusion adverse events
Blood platelets destined for transfusion release panoply of molecules during preparation and storage. The leukoreduction process made the transfusion safer but did not completely abolish the adverse events. The rationale is to study the proteome profile of platelet components SDA-PC (platelet pellet...
ORGANISM(S): Homo sapiens (Human) 
2019-02-13 | PXD008886 | Pride
Platelet concentrates (pc) Proteomics Transfusion Single donor apheresis-pc (sda-pc) 
ProteomicsPlatelet proteomics profiling in transfusion adverse events, part 2
Blood platelets destined for transfusion release panoply of molecules during preparation and storage. The leukoreduction process made the transfusion safer but did not completely abolish the adverse events. The rationale is to study the proteome profile of platelet components PPC (platelet pellets) ...
ORGANISM(S): Homo sapiens (Human) 
2019-02-13 | PXD003510 | Pride
Platelet concentrates (pc) Proteomics Buffy-coat-derived pooled pc (ppc) Transfusion 
UnknownWhole transcriptome analysis of platelet concentrates during storage.
Not available
S-EPMC10072990 | biostudies-literature
UnknownThree buffy coat platelet concentrates: Use of data modelling to make more with less.
Not available
S-EPMC12602124 | biostudies-literature
UnknownPlatelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma.
Not available
S-EPMC10072994 | biostudies-literature
UnknownModulation of Staphylococcus aureus gene expression during proliferation in platelet concentrates with focus on virulence and platelet functionality.
Not available
S-EPMC11271859 | biostudies-literature
UnknownHealth Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center.
Not available
S-EPMC10664333 | biostudies-literature
UnknownClinically Expired Platelet Concentrates as a Source of Extracellular Vesicles for Targeted Anti-Cancer Drug Delivery.
Not available
S-EPMC10056378 | biostudies-literature
UnknownThe neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates.
Not available
S-EPMC6822406 | biostudies-literature
Sort   by:  
 Page size